Carson Wealth (CWM LLC)
ANRO icon

Carson Wealth (CWM LLC)’s Alto Neuroscience ANRO Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.29K Sell
102
-52
-34% -$964 ﹤0.01% 5242
2025
Q4 		$3K Sell
154
-770
-83% -$9.7K ﹤0.01% 5029
2025
Q3 		$4K Sell
924
-2,845
-75% -$9.43K ﹤0.01% 4862
2025
Q2 		$8K Buy
3,769
+1,305
+53% +$3.1K ﹤0.01% 4417
2025
Q1 		$5K Buy
2,464
+2,146
+675% +$7.68K ﹤0.01% 4498
2024
Q4 		$1K Buy
318
+239
+303% +$1.49K ﹤0.01% 4841
2024
Q3 		$1K Buy
+79
New +$967 ﹤0.01% 4752

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ANRO Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Alto Neuroscience (ANRO) stake by 34% in Q1 2026, selling an estimated $964 and leaving 102 shares worth $2.29K. The position accounts for ﹤0.01% of the portfolio, ranked #5242.

Carson Wealth (CWM LLC) first reported a position in ANRO in Q3 2024 and has held it in 7 quarters since. The position peaked at $8K in Q2 2025. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Carson Wealth (CWM LLC) held 102 shares of Alto Neuroscience worth $2.29K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 52 Alto Neuroscience shares in Q1 2026, an estimated $964.
  • Alto Neuroscience made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5242 holding.
  • Carson Wealth (CWM LLC) first reported a position in Alto Neuroscience in Q3 2024 and has held it in 7 quarters since.
  • Carson Wealth (CWM LLC)'s Alto Neuroscience position peaked at $8K in Q2 2025.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.